The COVID-19 injections are Weapons of Mass Destruction designed to force cells to make Disease
- taylorpamela77
- Sep 3, 2023
- 3 min read
The engineered nanoparticles in the COVID-19 injections are nanotechnologies designed to force human cells to produce disease-causing pathogens known as spike proteins, spike proteins that are established lab-made pathogens that cause disease, disabilities, and death per dozens of scientific and clinical publications, abstracts, and patents as well as Pfizer’s internal documents and website (References 1-9).
WHEREAS COVID-19 injections as per Naik Ramachandra, PhD, Review Committee Chair, DVRPA/OVRR. BioNTech Manufacturing GmbH in partnership with Pfizer, Inc. "COMIRNATY (also referred to as BNT162b2 in this document) contains a nucleosidemodified messenger RNA (mRNA) encoding the viral spike glycoprotein (S) of SARSCoV-2" (Ref. 1).

WHEREAS COVID-19 injections as per FDA Nov 8, 2021 (Ref 1) Pfizer's COMIRNATY (also referred to as BNT162b2) is a state-of-the-art technology within a U.S. weapon system (Ref 10). As per National Archives and Declassification Interagency Security Classification Appeals Panel Redaction Codes (Ref 10) "declassified documents will usually contain redactions, which indicate portions that contain information not releasable to the public. Each redaction will be associated with a redaction code, which gives the reason for why the information cannot be released."

WHEREAS COVID-19 injections as per FDA Nov 8, 2021 (Ref 1) Pfizer's COMIRNATY (also referred to as BNT162b2) is a state-of-the-art technology within a U.S. weapon system this is mentioned in COMIRNATY Manufacturing Overview.

WHEREAS COVID-19 injections as per FDA Nov 8, 2021 (Ref 1) Pfizer's COMIRNATY (also referred to as BNT162b2) is a state-of-the-art technology within a U.S. weapon system this is mentioned when describing the Drug Product.

WHEREAS COVID-19 injections as per FDA Nov 8, 2021 (Ref 1) Pfizer's COMIRNATY (also referred to as BNT162b2) is a state-of-the-art technology within a U.S. weapon system this is mentioned when discussing the Stability of COMIRNATY in Multiple Dose Vial.

WHEREAS COVID-19 injections as per FDA Nov 8, 2021 (Ref 1) Pfizer's COMIRNATY (also referred to as BNT162b2) is a state-of-the-art technology within a U.S. weapon system this is mentioned when discussing the Testing Specification.


WHEREAS the engineered nanoparticle technologies (aka vaccine nanotechnology) in the COVID-19 mRNA injections are patented for use as a nanocarrier of a toxin, a chemical weapon, a bioweapon, a cancer-causing agent, an AIDS causing agent, an agent of biowarfare, a hazardous environmental agent. per US Patent Number 9539210, VACCINE NANOTECHNOLOGY (Ref 10 & 11).

WHEREAS COVID-19 injections containing engineered mRNA nanoparticle technologies meet the legal definition of biological weapons which is a biological agent, toxin and/or delivery device for use other than prophylactic (preventative), protective, bona fide research, or other peaceful purpose; and,
WHEREAS COVID-19 injections as meet the legal definition of chemical weapons which is a chemical agent, toxin and/or delivery device for use other than prophylactic (preventative), protective, bona fide research, or other peaceful purpose; and,
WHEREAS COVID-19 injections as meet the legal definition of toxins, poisons, and weapons of mass destruction as they are a biological, or chemical weapon able to cause widespread devastation and loss of life.
WHEREAS, a person who manufactures, possesses, sells, delivers, displays, uses, attempts to use, or conspires to use, or who makes readily accessible to others a weapon of mass destruction, chemical weapons, poisons, toxins, biological weapons commit a Crime.
References
1. Naik Ramachandra, PhD, Review Committee Chair, DVRPA/OVRR. BioNTech Manufacturing GmbH in partnership with Pfizer, Inc. “COMIRNATY (BNT162b2): Active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older” FDA Approval of the Biological License Application (BLA) for BNT162b2/COMIRNATY; Submitted May 18, 2021. Reviewed November 8, 2021. https://www.fda.gov/media/151733/download
2. 21 USC 225.1Vpume 4, Subpart A. Current Good Manufacturing Practice. 225.1 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=225.1
3. COMIRNATY Prescribing Information. Purple Cap. Dilute. April 2023. https://labeling.pfizer.com/ShowLabeling.aspx?id=15623
4. COMIRNATY Prescribing Information. Grey Cap. Do NOT dilute. April 2023.https://labeling.pfizer.com/ShowLabeling.aspx?id=16351
5. SPIKEVAX Prescribing Information. November 2022. https://www.fda.gov/media/155675/download
6. 21 U.S. Code § 351a2B - Adulterated drugs and devices, Chapter 9, Subchapter V, Part A https://www.law.cornell.edu/uscode/text/21/351#:~:text=For%20purposes%20of%20paragraph%20(a,the%20manufacturing%20of%20drugs%2C%20and
7. U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research. “Design and Analysis of Shedding Studies for Virus or Bacteria-Based Gene Therapy and Oncolytic Products” Guidance for Industry; Aug 2015. https://www.fda.gov/media/89036/download
8. Silver, Kate.“Shot of a Lifetime: How Pfizer Developed its Own Raw Materials to Ensure a Steady Supply for the COVID-19 Vaccine” Pfizer Website visited June 27, 2023. https://www.pfizer.com/news/articles/shot_of_a_lifetime_how_pfizer_developed_its_own_raw_materials_to_ensure_a_steady_supply_for_the_covid_19_vaccine
9. Karen Kingston. Karen Kingston is a med-legal advisor and biotech analyst with 25 years' experience. Unlocked Letter: The Intelligent and Brave Have Been Waiting for this Weapon (substack.com)
10. National Archives and Declassification Interagency Security Classification Appeals Panel Redaction Codes. Redaction Codes | National Archives
10. Pamela Taylor COVID19 injections containing engineered mRNA nanoparticle technologies are Weapons not vaccines. (taylorpamela77.wixsite.com)
10. NIH Patent for “Vaccine Nanotechnology” US 9,539,210 B2 Jan 10, 2017. https://patentimages.storage.googleapis.com/29/d1/ca/18013ced0621f0/US9539210.pdf
Comments